Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Solid Tumor 1 Sarcoma 1 Ovarian Cancer Recurrent 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Solid Tumors 1 Advanced Neoplastic Disease 1

Interventions

Carboplatin 369 Pemetrexed 310 pembrolizumab 303 Cisplatin 244 Paclitaxel 230 Docetaxel 199 Gemcitabine 130 Nivolumab 121 Erlotinib Hydrochloride 114 Bevacizumab 85 osimertinib 78 atezolizumab 65 durvalumab 58 Cetuximab 57 130-nm albumin-bound paclitaxel 56 Gefitinib 52 Ipilimumab 46 Afatinib 38 Drug Therapy 33 Cyclophosphamide 30 Crizotinib 30 Albumin-Bound Paclitaxel 30 Vinorelbine 28 tislelizumab 26 cemiplimab 26 avelumab 23 icotinib 22 Radiotherapy 22 capmatinib 21 Oxaliplatin 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Carcinoma, Non-Small-Cell Lung × AC 7700 × Clear all

NCT01263886 2015-12-21

DISRUPT

Sanofi

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡